- Filed
- Mar 31, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 13.27M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2024 | 12.5M sh |
| Capex | Q2 2026 · Sep 30, 2025 | $1.97M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2025 | −$2.09M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2024 | $1.7M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $1.89M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $2.37M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $8.7M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $3.46M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $2.93M |
| Stockholders Equity | Q2 2026 · Mar 31, 2024 | $2.02M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $2.95M |
| Current Liabilities | Q2 2026 · Mar 31, 2025 | $3.09M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $2.95M |
| Total Liabilities | Q2 2026 · Mar 31, 2025 | $3.09M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $8.93M |
| Current Assets | Q2 2026 · Mar 31, 2025 | $6.54M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $11.65M |
| Total Assets | Q2 2026 · Mar 31, 2025 | $6.55M |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | $0.01 |
| Eps Diluted | Q2 2026 · Sep 30, 2024 | $0.06 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | $0.01 |
| Eps Basic | Q2 2026 · Sep 30, 2024 | $0.06 |
| Sga Expense | Q2 2026 · Sep 30, 2025 | $322.26K |
| Sga Expense | Q2 2026 · Sep 30, 2024 | $102.82K |
| Net Income | Q2 2026 · Sep 30, 2025 | $146.78K |
| Net Income | Q2 2026 · Sep 30, 2024 | $743.74K |
| Operating Income | Q2 2026 · Sep 30, 2025 | $130.34K |
| Operating Income | Q2 2026 · Sep 30, 2024 | $865.51K |
| Gross Profit | Q2 2026 · Sep 30, 2025 | $452.6K |
| Gross Profit | Q2 2026 · Sep 30, 2024 | $968.33K |
| Cost Of Revenue | Q2 2026 · Sep 30, 2025 | $8.94M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2024 | $10.65M |
| Revenue | Q2 2026 · Sep 30, 2025 | $9.4M |
| Revenue | Q2 2026 · Sep 30, 2024 | $11.61M |